Uterine involution is the physiological process through which the uterus gradually returns towards its pre-pregnancy size following childbirth. It is an important component of postpartum recovery and is influenced by uterine contraction, placental-site healing, and the resolution of pregnancy-related changes. In Ayurveda, postnatal care, or Sutika Paricharya, includes traditional dietary and herbal practices intended to support maternal recovery. Dashamoola Kwatha, a decoction prepared from a group of ten medicinal roots, is associated with traditional Ayurvedic practice. However, its specific efficacy and safety for promoting postnatal uterine involution have not been established by sufficient high-quality clinical evidence.
Traditional rationale and proposed role
- Dashamoola is traditionally used in Ayurvedic practice for its described anti-inflammatory and pain-relieving properties.
- Its use during the postpartum period is based on traditional therapeutic principles rather than conclusive clinical evidence demonstrating accelerated uterine involution.
- The composition, preparation method, dose, and duration of use may also vary across formulations and clinical settings.
- Evidence from other herbal preparations should not be interpreted as evidence for Dashamoola Kwatha. Ho et al. reported associations between uterine involution and the use of Eucommia ulmoides and Sheng-hua-tang, a traditional Chinese herbal preparation.
- These findings do not establish the efficacy of Dashamoola Kwatha because the herbs and formulations studied were different, and the observational design could not establish causation.1
Clinical considerations in postpartum care
The potential use of Dashamoola Kwatha should be considered in the context of routine postpartum assessment and maternal safety.
- Assessment of uterine involution: Uterine tone, fundal height, vaginal bleeding, temperature, pulse, and associated symptoms should be assessed as clinically appropriate during postpartum care.2
- Recognition of complications: Persistent or increasing vaginal bleeding, fever, uterine tenderness, significant abdominal pain, or foul-smelling vaginal discharge requires prompt clinical assessment. These findings may indicate complications such as retained products of conception or postpartum infection.3
- Herbal product quality: The botanical identity, ingredient composition, preparation, and quality of the product should be verified. Contamination, inconsistent concentrations, and variation between preparations may affect safety.
- Breastfeeding considerations: Reliable evidence on the transfer of Dashamoola constituents into breast milk and their effects on breastfeeding infants is limited. Use during lactation should therefore be discussed with a qualified healthcare professional.
- Avoidance of treatment delays: Dashamoola Kwatha should not replace recommended obstetric assessment or established treatment for postpartum haemorrhage, infection, or suspected delayed uterine involution.
Evidence and research priorities
- Further research is needed to determine whether Dashamoola Kwatha has a measurable effect on uterine involution.
- Well-designed clinical studies should use a clearly defined and standardized formulation, specify dose and duration, and assess outcomes such as uterine size, bleeding patterns, adverse effects, and maternal recovery.
- Safety during lactation should also be evaluated. Dashamoola Kwatha accelerates uterine involution or prevents postpartum complications should be avoided.1
Conclusion
Dashamoola Kwatha has a traditional role within Ayurvedic postpartum care, but its specific effectiveness for postnatal uterine involution remains uncertain. Its use should be approached cautiously, particularly during breastfeeding, and should not delay assessment or treatment of postpartum complications. Clinical recommendations should be based on established postpartum care practices and evidence specific to the formulation being considered.
References
- Ho M, Li TC, Su SY. The association between traditional Chinese dietary and herbal therapies and uterine involution in postpartum women. Evid Based Complement Alternat Med. 2011;2011:918291. doi:10.1155/2011/918291. https://doi.org/10.1155/2011/918291
- World Health Organization. WHO Recommendations on Maternal and Newborn Care for a Positive Postnatal Experience. World Health Organization; 2022. https://www.ncbi.nlm.nih.gov/books/NBK579650/
- National Institute for Health and Care Excellence. Postnatal Care. NICE guideline NG194. https://www.nice.org.uk/guidance/ng194/chapter/recommendations